Correlation Between Vera Therapeutics and Bruker

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vera Therapeutics and Bruker at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vera Therapeutics and Bruker into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vera Therapeutics and Bruker, you can compare the effects of market volatilities on Vera Therapeutics and Bruker and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vera Therapeutics with a short position of Bruker. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vera Therapeutics and Bruker.

Diversification Opportunities for Vera Therapeutics and Bruker

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vera and Bruker is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Vera Therapeutics and Bruker in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bruker and Vera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vera Therapeutics are associated (or correlated) with Bruker. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bruker has no effect on the direction of Vera Therapeutics i.e., Vera Therapeutics and Bruker go up and down completely randomly.

Pair Corralation between Vera Therapeutics and Bruker

Given the investment horizon of 90 days Vera Therapeutics is expected to generate 2.64 times more return on investment than Bruker. However, Vera Therapeutics is 2.64 times more volatile than Bruker. It trades about 0.07 of its potential returns per unit of risk. Bruker is currently generating about 0.0 per unit of risk. If you would invest  1,950  in Vera Therapeutics on September 3, 2024 and sell it today you would earn a total of  3,025  from holding Vera Therapeutics or generate 155.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vera Therapeutics  vs.  Bruker

 Performance 
       Timeline  
Vera Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Vera Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Vera Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Bruker 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bruker has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward-looking signals remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Vera Therapeutics and Bruker Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vera Therapeutics and Bruker

The main advantage of trading using opposite Vera Therapeutics and Bruker positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vera Therapeutics position performs unexpectedly, Bruker can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will offset losses from the drop in Bruker's long position.
The idea behind Vera Therapeutics and Bruker pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity